{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:10:47Z","timestamp":1790712647368,"version":"4.1.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:00:00Z","timestamp":1667347200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Geriatr Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>To provide an overview of the current deprescribing attitudes, practices, and approaches of geriatricians and geriatricians-in-training across Europe.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>An online survey was disseminated among European geriatricians and geriatricians-in-training. The survey comprised Likert scale and multiple-choice questions on deprescribing approaches and practices, deprescribing education and knowledge, and facilitators\/barriers of deprescribing. Responses to the survey questions and participant characteristics were quantified and differences evaluated between geriatricians and geriatricians-in-training and between European regions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The 964 respondents (median age 42\u00a0years old; 64% female; 21% geriatricians-in-training) were generally willing to deprescribe (98%) and felt confident about deprescribing (85%). Despite differences across European regions, the most commonly reported reasons for deprescribing were functional impairment and occurrence of adverse drug reactions. The most important barriers for deprescribing were patients\u2019 unwillingness, fear of negative consequences, lack of time, and poor communication between multiple prescribers. Perceived risk of adverse drug reactions was highest for psychotropic drugs, nonsteroidal anti-inflammatory drugs, cardiovascular drugs, and opioid analgesics. Only one in four respondents (23% of geriatricians and 37% of geriatricians-in-training) think education in medical school had sufficiently prepared them for deprescribing in clinical practice. They reported that their future deprescribing activities would probably increase with improved information sharing between various prescribers, deprescribing recommendations in guidelines, and increased education and training. Approximately 90% think that a paradigm shift is required for prescribers and patients, increasing focus on the possible benefits of deprescribing (potentially) inappropriate medications.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Based on the outcomes of this survey, we recommend investing in improved inter-professional communication, better education and evidence-based recommendations to improve future patient-centered deprescribing practices.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s41999-022-00702-9","type":"journal-article","created":{"date-parts":[[2022,11,2]],"date-time":"2022-11-02T00:18:41Z","timestamp":1667348321000},"page":"1455-1466","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Deprescribing practices, habits and attitudes of geriatricians and geriatricians-in-training across Europe: a large web-based survey"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2021-5602","authenticated-orcid":false,"given":"Eveline P.","family":"van Poelgeest","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lotta J.","family":"Seppala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihoo M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclistan","family":"Bahat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birkan","family":"Ilhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda H.","family":"Lavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana","family":"Mair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob J.","family":"van Marum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Onder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Ryg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00edlia Andreia","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Garfinkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A\u00f0alsteinn","family":"Gu\u00f0mundsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirpa","family":"Hartikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Kotsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Montero-Errasqu\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Neumann-Podczaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhad","family":"Pazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Soulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Vankova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Wieczorowska\u2013Tobis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"van der Velde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On Behalf of the EuGMS SIG Pharmacology","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,2]]},"reference":[{"issue":"7","key":"702_CR1","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s40266-018-0554-2","volume":"35","author":"D Mangin","year":"2018","unstructured":"Mangin D, Bahat G, Golomb BA et al (2018) International group for reducing inappropriate medication use & polypharmacy (IGRIMUP): position statement and 10 recommendations for action. Drug Aging 35(7):575\u2013587. https:\/\/doi.org\/10.1007\/s40266-018-0554-2","journal-title":"Drug Aging"},{"key":"702_CR2","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2147\/CLEP.S153458","volume":"10","author":"L Morin","year":"2018","unstructured":"Morin L, Johnell K, Laroche ML, Fastbom J, Wastesson JW (2018) The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol 10:289\u2013298. https:\/\/doi.org\/10.2147\/CLEP.S153458","journal-title":"Clin Epidemiol"},{"key":"702_CR3","unstructured":"Kornholt J, Christensen MB (2020) Prevalence of polypharmacy in Denmark. Dan Med J 67(6)"},{"issue":"2","key":"702_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3109\/13685538.2013.771329","volume":"16","author":"G Bahat","year":"2013","unstructured":"Bahat G, Tufan F, Bahat Z et al (2013) Assessments of functional status, comorbidities, polypharmacy, nutritional status and sarcopenia in Turkish community-dwelling male elderly. Aging Male 16(2):67\u201372. https:\/\/doi.org\/10.3109\/13685538.2013.771329","journal-title":"Aging Male"},{"key":"702_CR5","unstructured":"Organization WH (2019) Medication safety in polypharmacy: Technical report."},{"issue":"9","key":"702_CR6","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM et al (2012) Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol 65(9):989\u2013995. https:\/\/doi.org\/10.1016\/j.jclinepi.2012.02.018","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"702_CR7","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1517\/14740338.2013.827660","volume":"13","author":"RL Maher","year":"2014","unstructured":"Maher RL, Hanlon J, Hajjar ER (2014) Clinical consequences of polypharmacy in elderly. Expert Opin Drug Saf 13(1):57\u201365. https:\/\/doi.org\/10.1517\/14740338.2013.827660","journal-title":"Expert Opin Drug Saf"},{"issue":"3","key":"702_CR8","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1080\/17512433.2020.1730812","volume":"13","author":"M Sawan","year":"2020","unstructured":"Sawan M, Reeve E, Turner J et al (2020) A systems approach to identifying the challenges of implementing deprescribing in older adults across different health care settings and countries: a narrative review. Expert Rev Clin Phar 13(3):233\u2013245. https:\/\/doi.org\/10.1080\/17512433.2020.1730812","journal-title":"Expert Rev Clin Phar"},{"issue":"9","key":"702_CR9","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/ggi.12850","volume":"17","author":"G Bahat","year":"2017","unstructured":"Bahat G, Bay I, Tufan A, Tufan F, Kilic C, Karan MA (2017) Prevalence of potentially inappropriate prescribing among older adults: a comparison of the Beers 2012 and Screening Tool of Older Person\u2019s Prescriptions criteria version 2. Geriatr Gerontol Int 17(9):1245\u20131251. https:\/\/doi.org\/10.1111\/ggi.12850","journal-title":"Geriatr Gerontol Int"},{"issue":"4","key":"702_CR10","doi-asserted-by":"publisher","first-page":"e0195232","DOI":"10.1371\/journal.pone.0195232","volume":"13","author":"J McIntosh","year":"2018","unstructured":"McIntosh J, Alonso A, MacLure K et al (2018) A case study of polypharmacy management in nine European countries: implications for change management and implementation. PLoS ONE 13(4):e0195232. https:\/\/doi.org\/10.1371\/journal.pone.0195232","journal-title":"PLoS ONE"},{"issue":"1","key":"702_CR11","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/jgs.16157","volume":"68","author":"P Goyal","year":"2020","unstructured":"Goyal P, Anderson TS, Bernacki GM et al (2020) Physician perspectives on deprescribing cardiovascular medications for older adults. J Am Geriatr Soc 68(1):78\u201386. https:\/\/doi.org\/10.1111\/jgs.16157","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"702_CR12","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1177\/2042098615613984","volume":"6","author":"D Garfinkel","year":"2015","unstructured":"Garfinkel D, Ilhan B, Bahat G (2015) Routine deprescribing of chronic medications to combat polypharmacy. Ther Adv Drug Saf 6(6):212\u2013233. https:\/\/doi.org\/10.1177\/2042098615613984","journal-title":"Ther Adv Drug Saf"},{"key":"702_CR13","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1146\/annurev-pharmtox-010919-023508","volume":"60","author":"A Mair","year":"2020","unstructured":"Mair A, Wilson M, Dreischulte T (2020) Addressing the challenge of polypharmacy. Annu Rev Pharmacol 60:661\u2013681. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010919-023508","journal-title":"Annu Rev Pharmacol"},{"key":"702_CR14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2016.12.021","volume":"38","author":"E Reeve","year":"2017","unstructured":"Reeve E, Thompson W, Farrell B (2017) Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. Eur J Intern Med 38:3\u201311. https:\/\/doi.org\/10.1016\/j.ejim.2016.12.021","journal-title":"Eur J Intern Med"},{"key":"702_CR15","doi-asserted-by":"publisher","first-page":"008165","DOI":"10.1002\/14651858.CD008165.pub3","volume":"10","author":"SM Patterson","year":"2014","unstructured":"Patterson SM, Cadogan CA, Kerse N et al (2014) Interventions to improve the appropriate use of polypharmacy for older people. Cochrane Db Syst Rev 10:008165. https:\/\/doi.org\/10.1002\/14651858.CD008165.pub3","journal-title":"Cochrane Db Syst Rev"},{"key":"702_CR16","doi-asserted-by":"publisher","first-page":"009095","DOI":"10.1002\/14651858.CD009095.pub3","volume":"2","author":"DP Alldred","year":"2016","unstructured":"Alldred DP, Kennedy MC, Hughes C, Chen TF, Miller P (2016) Interventions to optimise prescribing for older people in care homes. Cochrane Db Syst Rev. 2:009095. https:\/\/doi.org\/10.1002\/14651858.CD009095.pub3","journal-title":"Cochrane Db Syst Rev."},{"issue":"2","key":"702_CR17","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1111\/jgs.15195","volume":"66","author":"SL Gray","year":"2018","unstructured":"Gray SL, Hart LA, Perera S, Semla TP, Schmader KE, Hanlon JT (2018) Meta-analysis of interventions to reduce adverse drug reactions in older adults. J Am Geriatr Soc 66(2):282\u2013288. https:\/\/doi.org\/10.1111\/jgs.15195","journal-title":"J Am Geriatr Soc"},{"issue":"9","key":"702_CR18","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1111\/jgs.17273","volume":"69","author":"KM Zimmerman","year":"2021","unstructured":"Zimmerman KM, Linsky AM (2021) A narrative review of updates in deprescribing research. J Am Geriatr Soc 69(9):2619\u20132624. https:\/\/doi.org\/10.1111\/jgs.17273","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"702_CR19","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S (2015) A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Brit J Clin Pharmaco 80(6):1254\u20131268. https:\/\/doi.org\/10.1111\/bcp.12732","journal-title":"Brit J Clin Pharmaco"},{"key":"702_CR20","unstructured":"Medication Safety in Polypharmacy. Geneva: World Health Organization; 2019 (WHO\/UHC\/SDS\/2019.11)"},{"key":"702_CR21","unstructured":"Medication Without Harm - Global Patient Safety Challenge on Medication Safety. Geneva: World Health Organization, 2017. Licence: CC BY-NC-SA 3.0 IGO"},{"issue":"4","key":"702_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0122246","volume":"10","author":"B Farrell","year":"2015","unstructured":"Farrell B, Tsang C, Raman-Wilms L, Irving H, Conklin J, Pottie K (2015) What are priorities for deprescribing for elderly patients? Capturing the voice of practitioners: a modified Delphi process. PLoS ONE 10(4):e0122246. https:\/\/doi.org\/10.1371\/journal.pone.0122246","journal-title":"PLoS ONE"},{"issue":"2","key":"702_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1007\/s41999-021-00599-w","volume":"13","author":"KJ Ploegmakers","year":"2022","unstructured":"Ploegmakers KJ, Medlock S, Linn AJ et al (2022) Barriers and facilitators in using a clinical decision support system for fall risk management for older people: a European survey. Eur Geriatr Med 13(2):395\u2013405. https:\/\/doi.org\/10.1007\/s41999-021-00599-w","journal-title":"Eur Geriatr Med"},{"issue":"17","key":"702_CR24","doi-asserted-by":"publisher","first-page":"2967","DOI":"10.1016\/j.ejca.2009.06.001","volume":"45","author":"JC van Weert","year":"2009","unstructured":"van Weert JC, Jansen J, de Bruijn GJ, Noordman J, van Dulmen S, Bensing JM (2009) QUOTEchemo: a patient-centred instrument to measure quality of communication preceding chemotherapy treatment through the patient\u2019s eyes. Eur J Cancer 45(17):2967\u20132976. https:\/\/doi.org\/10.1016\/j.ejca.2009.06.001","journal-title":"Eur J Cancer"},{"issue":"4","key":"702_CR25","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/bcp.12386","volume":"78","author":"E Reeve","year":"2014","unstructured":"Reeve E, Shakib S, Hendrix I, Roberts MS, Wiese MD (2014) Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. Brit J Clin Pharmaco 78(4):738\u2013747. https:\/\/doi.org\/10.1111\/bcp.12386","journal-title":"Brit J Clin Pharmaco"},{"issue":"1","key":"702_CR26","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17512433.2020.1697676","volume":"13","author":"D O'Mahony","year":"2020","unstructured":"O\u2019Mahony D (2020) STOPP\/START criteria for potentially inappropriate medications\/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Phar 13(1):15\u201322. https:\/\/doi.org\/10.1080\/17512433.2020.1697676","journal-title":"Expert Rev Clin Phar"},{"issue":"1","key":"702_CR27","first-page":"56","volume":"101","author":"L Croke","year":"2020","unstructured":"Croke L (2020) Beers criteria for inappropriate medication use in older patients: an update from the AGS. Am Fam Physician 101(1):56\u201357","journal-title":"Am Fam Physician"},{"issue":"2","key":"702_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ageing\/afaa159","volume":"50","author":"D Curtin","year":"2021","unstructured":"Curtin D, Gallagher P, O\u2019Mahony D (2021) Deprescribing in older people approaching end-of-life: development and validation of STOPPFrail version 2. Age Ageing 50(2):465\u2013471. https:\/\/doi.org\/10.1093\/ageing\/afaa159","journal-title":"Age Ageing"},{"key":"702_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/ageing\/afaa249","author":"LJ Seppala","year":"2020","unstructured":"Seppala LJ, Petrovic M, Ryg J et al (2020) STOPPFall (screening tool of older persons prescriptions in older adults with high fall risk): a Delphi study by the EuGMS task and finish group on fall-risk-increasing drugs. Age Ageing. https:\/\/doi.org\/10.1093\/ageing\/afaa249","journal-title":"Age Ageing"},{"issue":"675","key":"702_CR30","doi-asserted-by":"publisher","first-page":"E663","DOI":"10.3399\/bjgp18X699041","volume":"68","author":"SL Thio","year":"2018","unstructured":"Thio SL, Nam J, van Driel ML, Dirven T, Blom JW (2018) Effects of discontinuation of chronic medication in primary care: a systematic review of deprescribing trials. Brit J Gen Pract 68(675):E663\u2013E672. https:\/\/doi.org\/10.3399\/bjgp18X699041","journal-title":"Brit J Gen Pract"},{"key":"702_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s12875-018-0855-x","author":"AG Strehlau","year":"2018","unstructured":"Strehlau AG, Larsen MD, Sondergaard J, Almarsdottir AB, Rosholm JU (2018) General practitioners\u2019 continuation and acceptance of medication changes at sectorial transitions of geriatric patients\u2014a qualitative interview study. Bmc Fam Pract. https:\/\/doi.org\/10.1186\/s12875-018-0855-x","journal-title":"Bmc Fam Pract"},{"issue":"1","key":"702_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1093\/ageing\/afz133","volume":"49","author":"S Scott","year":"2020","unstructured":"Scott S, Twigg MJ, Clark AB et al (2020) Development of a hospital deprescribing implementation framework: a focus group study with geriatricians and pharmacists. Age Ageing 49(1):102\u2013110. https:\/\/doi.org\/10.1093\/ageing\/afz133","journal-title":"Age Ageing"},{"issue":"12","key":"702_CR33","doi-asserted-by":"publisher","first-page":"e006544","DOI":"10.1136\/bmjopen-2014-006544","volume":"4","author":"K Anderson","year":"2014","unstructured":"Anderson K, Stowasser D, Freeman C, Scott I (2014) Prescriber barriers and enablers to minimising potentially inappropriate medications in adults: a systematic review and thematic synthesis. BMJ Open 4(12):e006544. https:\/\/doi.org\/10.1136\/bmjopen-2014-006544","journal-title":"BMJ Open"},{"issue":"4","key":"702_CR34","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1370\/afm.2094","volume":"15","author":"KA Wallis","year":"2017","unstructured":"Wallis KA, Andrews A, Henderson M (2017) Swimming against the tide: primary care physicians\u2019 views on deprescribing in everyday practice. Ann Fam Med 15(4):341\u2013346. https:\/\/doi.org\/10.1370\/afm.2094","journal-title":"Ann Fam Med"},{"issue":"1","key":"702_CR35","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1093\/ijpp\/riab079","volume":"30","author":"CH Heinrich","year":"2022","unstructured":"Heinrich CH, Donovan MD (2022) Assessing community pharmacists\u2019 attitudes towards identifying opportunities for deprescribing in clinical practice in Ireland. Int J Pharm Pract 30(1):28\u201335. https:\/\/doi.org\/10.1093\/ijpp\/riab079","journal-title":"Int J Pharm Pract"},{"key":"702_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s41999-021-00595-0","author":"T Masud","year":"2022","unstructured":"Masud T, Ogliari G, Lunt E et al (2022) A scoping review of the changing landscape of geriatric medicine in undergraduate medical education: curricula, topics and teaching methods. Eur Geriatr Med. https:\/\/doi.org\/10.1007\/s41999-021-00595-0","journal-title":"Eur Geriatr Med."},{"issue":"10","key":"702_CR37","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1111\/bcp.14539","volume":"86","author":"RJ van Marum","year":"2020","unstructured":"van Marum RJ (2020) Underrepresentation of the elderly in clinical trials, time for action. Brit J Clin Pharmaco 86(10):2014\u20132016. https:\/\/doi.org\/10.1111\/bcp.14539","journal-title":"Brit J Clin Pharmaco"},{"issue":"2","key":"702_CR38","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14740338.2017.1265503","volume":"16","author":"D Stewart","year":"2017","unstructured":"Stewart D, Mair A, Wilson M et al (2017) Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments. Expert Opin Drug Saf 16(2):203\u2013213. https:\/\/doi.org\/10.1080\/14740338.2017.1265503","journal-title":"Expert Opin Drug Saf"},{"key":"702_CR39","doi-asserted-by":"crossref","unstructured":"Seppala LJea (2020) STOPPFall (screening tool of older persons prescriptions in older adults with high fall risk): a Delphi study by the EuGMS Task and Finish Group on Fall-Risk-Increasing Drugs. Accepted for publication in Age and Ageing","DOI":"10.1093\/ageing\/afaa249"},{"key":"702_CR40","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.maturitas.2019.10.013","volume":"131","author":"SC de Ruiter","year":"2020","unstructured":"de Ruiter SC, Biesheuvel SS, van Haelst IMM, van Marum RJ, Jansen R (2020) To STOPP or to START? Potentially inappropriate prescribing in older patients with falls and syncope. Maturitas 131:65\u201371. https:\/\/doi.org\/10.1016\/j.maturitas.2019.10.013","journal-title":"Maturitas"},{"key":"702_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-020-01953-6","author":"KT Jungo","year":"2021","unstructured":"Jungo KT, Mantelli S, Rozsnyai Z et al (2021) General practitioners\u2019 deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries. Bmc Geriatr. https:\/\/doi.org\/10.1186\/s12877-020-01953-6","journal-title":"Bmc Geriatr"},{"key":"702_CR42","doi-asserted-by":"publisher","first-page":"3793","DOI":"10.2147\/Ijgm.S253177","volume":"14","author":"H Wu","year":"2021","unstructured":"Wu H, O\u2019Donnell LK, Fujita K, Masnoon N, Hilmer SN (2021) Deprescribing in the older patient: a narrative review of challenges and solutions. Int J Gen Med 14:3793\u20133807. https:\/\/doi.org\/10.2147\/Ijgm.S253177","journal-title":"Int J Gen Med"}],"container-title":["European Geriatric Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-022-00702-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s41999-022-00702-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s41999-022-00702-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,5]],"date-time":"2022-12-05T09:08:47Z","timestamp":1670231327000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s41999-022-00702-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,2]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1007\/s41999-022-00702-9","relation":{},"ISSN":["1878-7657"],"issn-type":[{"value":"1878-7657","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,2]]},"assertion":[{"value":"11 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol and survey questionnaire were send to the medical ethical committee of the Academic Medical Centre of the University of Amsterdam who ruled that no formal ethical approval was required for this study (W21_145#21.160). The study was approved by the local Research Ethics Committees of Ireland, Spain, Turkey, Poland and Belgium.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Digital informed consent was obtained from all participants before participation to the survey.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable (survey among physicians; no patient data).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}